Skip to main content

Cancer Immunology, Immunotherapy

Ausgabe 9/2004

Inhalt (11 Artikel)

Review

Immunotherapy in multiple myeloma: Id-specific strategies suggested by studies in animal models

Alexandre Corthay, Katrin U. Lundin, Ludvig A. Munthe, Marianne Frøyland, Tobias Gedde-Dahl, Zlatko Dembic, Bjarne Bogen

Original Article

Expression of IAP family proteins in colon cancers from patients with different age groups

T. Endo, S. Abe, H. B. K. Seidlar, S. Nagaoka, T. Takemura, M. Utsuyama, M. Kitagawa, K. Hirokawa

Original Article

Dendritic cells can be rapidly expanded ex vivo and safely administered in patients with metastatic breast cancer

E. Claire Dees, Karen P. McKinnon, Jennifer J. Kuhns, Kathryn A. Chwastiak, Scotty Sparks, Mary Myers, Edward J. Collins, Jeffrey A. Frelinger, Henrik Van Deventer, Frances Collichio, Lisa A. Carey, Mark E. Brecher, Mark Graham, H. Shelton Earp, Jonathan S. Serody

Original Article

Correlation between interleukin 6 production and tumor proliferation in non-small cell lung cancer

Haruko Yamaji, Toshihiko Iizasa, Eitetsu Koh, Makoto Suzuki, Mizuto Otsuji, Hao Chang, Shinichiro Motohashi, Sana Yokoi, Kenzo Hiroshima, Masatoshi Tagawa, Toshinori Nakayama, Takehiko Fujisawa

Original Article

Efficient generation of antileukemic autologous T cells by short-term culture and γ-irradiation of myeloid leukemic cells

Rodolphe Vereecque, Aurore Saudemont, Stéphane Depil, Selim Corm, Joris Andrieux, Valérie Soenen-Cornu, Bruno Quesnel

Original Article

Activated vitronectin as a target for anticancer therapy with human antibodies

Haiko J. Bloemendal, Hetty C. de Boer, Elianne A. Koop, Alice J. van Dongen, Roel Goldschmeding, Wil J. M. Landman, Ton Logtenberg, Martijn F. B. G. Gebbink, Emile E. Voest

Original Article

A phase I trial of idiotypic vaccination with HMFG1 in ovarian cancer

Steve Nicholson, C. C. Bomphray, H. Thomas, A. McIndoe, D. Barton, M. Gore, Andrew J. T. George

Original Article

Proteasomal cleavage does not determine immunogenicity of gp100-derived peptides gp100209-217 and gp100209-217T210M

Dirk Nagorsen, Catherine Servis, Nicole Lévy, Maurizio Provenzano, Mark E. Dudley, Francesco M. Marincola, Frédéric Lévy

Original Article

Heat shock protein 70 / MAGE-1 tumor vaccine can enhance the potency of MAGE-1–specific cellular immune responses in vivo

Jing Ye, Guang-Sheng Chen, Hong-Ping Song, Zeng-Shan Li, Ya-Yu Huang, Ping Qu, Yu-Jing Sun, Xiu-Min Zhang, Yan-Fang Sui

Original Article

Monitoring the level of complement components during autologous blood stem cell transplantation in patients with malignant lymphomas

Aniko Banyai, Lilian Varga, Aniko Barta, Laszlo Gopcsa, Katalin Paloczi

Letter to the Editors

Immunotherapy with histamine and interleukin 2 in malignant melanoma with liver metastasis

Sanjiv S. Agarwala, Kristoffer Hellstrand, Kurt Gehlsen, Peter Naredi

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.